ORF9p phosphorylation by ORF47p Is crucial for the formation and egress of varicella-Zoster virus viral particles

Journal of Virology

Volumn 87, Issue 5, 2013, Pages 2868-2881

  Riva, Laura ^a   Thiry, Marc ^a   Bontems, Sebastien ^a,b   Joris, Aline ^a   Piette, Jacques ^a   Lebrun, Marielle ^a   Sadzot Delvaux, Catherine ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUTAMINE; OPEN READING FRAME 47 PROTEIN; OPEN READING FRAME 9 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL SURFACE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; VARICELLA ZOSTER VIRUS; VIRION; VIRUS ASSEMBLY; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS MORPHOLOGY; VIRUS MUTATION; VIRUS PARTICLE; VIRUS RELEASE;

CELL LINE, TUMOR; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DENDRITIC CELLS; HEK293 CELLS; HERPESVIRUS 3, HUMAN; HUMANS; MUTATION; OPEN READING FRAMES; PHOSPHORYLATION; PROTEIN KINASES; VIRAL PROTEINS; VIRAL STRUCTURAL PROTEINS; VIRION; VIRUS ASSEMBLY; VIRUS RELEASE; VIRUS REPLICATION;

EID: 84874746658     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02757-12     Document Type: Article

References (56)

1. Arvin AM. 1996. Varicella-zoster virus. Clin. Microbiol. Rev. 9:361-381.
2. Kinchington PR. 1999. Latency of varicella zoster virus; a persistently perplexing state. Front. Biosci. 4:D200-D211.
3. Cohen JI, Straus SE, Arvin AM. 2007. Varicella-zoster virus replication, pathogenesis, and management, p 2773-2818. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
4. Mettenleiter TC. 2002. Herpesvirus assembly and egress. J. Virol. 76: 1537-1547.
5. Kinchington PR, Bookey D, Turse SE. 1995. The transcriptional regulatory proteins encoded by varicella-zoster virus open reading frames (ORFs) 4 and 63, but not ORF 61, are associated with purified virus particles. J. Virol. 69:4274-4282.
6. Kinchington PR, Fite K, Seman A, Turse SE. 2001. Virion association of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, requires expression of the VZV open reading frame 66 protein kinase. J. Virol. 75:9106 -9113.
7. Che X, Reichelt M, Sommer MH, Rajamani J, Zerboni L, Arvin AM. 2008. Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in the pathogenesis of skin infection. J. Virol. 82: 5825-5834.
8. Spengler M, Niesen N, Grose C, Ruyechan WT, Hay J. 2001. Interactions among structural proteins of varicella zoster virus. Arch. Virol. Suppl. 2001:71-79.
9. Heineman TC, Cohen JI. 1995. The varicella-zoster virus (VZV) open reading frame 47 (ORF47) protein kinase is dispensable for viral replication and is not required for phosphorylation of ORF63 protein, the VZV homolog of herpes simplex virus ICP22. J. Virol. 69:7367-7370.
10. Moffat JF, Zerboni L, Sommer MH, Heineman TC, Cohen JI, Kaneshima H, Arvin AM. 1998. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc. Natl. Acad. Sci. U. S. A. 95:11969- 11974.
11. Hu H, Cohen JI. 2005. Varicella-zoster virus open reading frame 47 (ORF47) protein is critical for virus replication in dendritic cells and for spread to other cells. Virology 337:304-311.
12. Besser J, Ikoma M, Fabel K, Sommer MH, Zerboni L, Grose C, Arvin AM. 2004. Differential requirement for cell fusion and virion formation in the pathogenesis of varicella-zoster virus infection in skin and T cells. J. Virol. 78:13293-13305.
13. Kenyon TK, Homan E, Storlie J, Ikoma M, Grose C. 2003. Comparison of varicella-zoster virus ORF47 protein kinase and casein kinase II and their substrates. J. Med. Virol. 70(Suppl 1):S95-S102.
14. Kenyon TK, Grose C. 2010. VZV ORF47 serine protein kinase and its viral substrates. Curr. Top. Microbiol. Immunol. 342:99-111.
15. Kenyon TK, Lynch J, Hay J, Ruyechan W, Grose C. 2001. Varicellazoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63. J. Virol. 75:8854-8858.
16. Reddy SM, Cox E, Iofin I, Soong W, Cohen JI. 1998. Varicella-zoster virus (VZV) ORF32 encodes a phosphoprotein that is posttranslationally modified by the VZV ORF47 protein kinase. J. Virol. 72:8083-8088.
17. Kenyon TK, Cohen JI, Grose C. 2002. Phosphorylation by the varicellazoster virus ORF47 protein serine kinase determines whether endocytosed viral gE traffics to the trans-Golgi network or recycles to the cell membrane. J. Virol. 76:10980-10993.
18. Besser J, Sommer MH, Zerboni L, Bagowski CP, Ito H, Moffat J, Ku CC, Arvin AM. 2003. Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse. J. Virol. 77:5964-5974.
19. Ng TI, Keenan L, Kinchington PR, Grose C. 1994. Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J. Virol. 68:1350-1359.
20. Vandevenne P, Lebrun M, El Mjiyad N, Ote I, Di Valentin E, Habraken Y, Dortu E, Piette J, Sadzot-Delvaux C. 2011. The varicella-zoster virus ORF47 kinase interferes with host innate immune response by inhibiting the activation of IRF3. PLoS One 6:e16870. doi:10.1371/journal.pone .0016870.
21. Ng TI, Ogle WO, Roizman B. 1998. UL13 protein kinase of herpes simplex virus 1 complexes with glycoprotein E and mediates the phosphorylation of the viral Fc receptor: glycoproteins E and I. Virology 241: 37-48.
22. Asai R, Ohno T, Kato A, Kawaguchi Y. 2007. Identification of proteins directly phosphorylated by UL13 protein kinase from herpes simplex virus 1. Microbes Infect. 9:1434-1438.
23. Cohrs RJ, Hurley MP, Gilden DH. 2003. Array analysis of viral gene transcription during lytic infection of cells in tissue culture with varicellazoster virus. J. Virol. 77:11718-11732.
24. Kennedy PG, Grinfeld E, Craigon M, Vierlinger K, Roy D, Forster T, Ghazal P. 2005. Transcriptomal analysis of varicella-zoster virus infection using long oligonucleotide-based microarrays. J. Gen. Virol. 86:2673-2684.
25. Dorange F, Tischer BK, Vautherot JF, Osterrieder N. 2002. Characterization of Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth. J. Virol. 76:1959-1970.
26. Tischer BK, Kaufer BB, Sommer M, Wussow F, Arvin AM, Osterrieder N. 2007. A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9. J. Virol. 81:13200-13208.
27. del Rio T, Werner HC, Enquist LW. 2002. The pseudorabies virus VP22 homologue (UL49) is dispensable for virus growth in vitro and has no effect on virulence and neuronal spread in rodents. J. Virol. 76:774-782.
28. Duffy C, Lavail JH, Tauscher AN, Wills EG, Blaho JA, Baines JD. 2006. Characterization of a UL49-null mutant: VP22 of herpes simplex virus type 1 facilitates viral spread in cultured cells and the mouse cornea. J. Virol. 80:8664-8675.
29. Cilloniz C, Jackson W, Grose C, Czechowski D, Hay J, Ruyechan WT. 2007. The varicella-zoster virus (VZV) ORF9 protein interacts with the IE62 major VZV transactivator. J. Virol. 81:761-774.
30. Uetz P, Dong YA, Zeretzke C, Atzler C, Baiker A, Berger B, Rajagopala SV, Roupelieva M, Rose D, Fossum E, Haas J. 2006. Herpesviral protein networks and their interaction with the human proteome. Science 311: 239-242.
31. Stellberger T, Hauser R, Baiker A, Pothineni VR, Haas J, Uetz P. 2010. Improving the yeast two-hybrid system with permutated fusions proteins: the varicella zoster virus interactome. Proteome Sci. 8:8.
32. Heineman TC, Seidel K, Cohen JI. 1996. The varicella-zoster virus ORF66 protein induces kinase activity and is dispensable for viral replication. J. Virol. 70:7312-7317.
33. Zhang Z, Huang Y, Zhu H. 2008. A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC system. J. Virol. Methods 148:197-204.
34. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG. 2005. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33:e36. doi:10.1093/nar/gni035.
35. Kennedy PG, Grinfeld E, Bontems S, Sadzot-Delvaux C. 2001. Varicellazoster virus gene expression in latently infected rat dorsal root ganglia. Virology 289:218-223.
36. Nikkels AF, Debrus S, Sadzot-Delvaux C, Piette J, Delvenne P, Rentier B, Pierard GE. 1993. Comparative immunohistochemical study of herpes simplex and varicella-zoster infections. Virchows Arch. A Pathol. Anat. Histopathol. 422:121-126.
37. Cohen JI, Seidel K. 1994. Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro. J. Virol. 68:7850-7858.
38. Blom N, Gammeltoft S, Brunak S. 1999. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294: 1351-1362.
39. Elliott G, O'Reilly D, O'Hare P. 1996. Phosphorylation of the herpes simplex virus type 1 tegument protein VP22. Virology 226:140-145.
40. Geiss BJ, Tavis JE, Metzger LM, Leib DA, Morrison LA. 2001. Temporal regulation of herpes simplex virus type 2 VP22 expression and phosphorylation. J. Virol. 75:10721-10729.
41. Elliott G, O'Hare P. 1998. Herpes simplex virus type 1 tegument protein VP22 induces the stabilization and hyperacetylation of microtubules. J. Virol. 72:6448-6455.
42. Kotsakis A, Pomeranz LE, Blouin A, Blaho JA. 2001. Microtubule reorganization during herpes simplex virus type 1 infection facilitates the nuclear localization of VP22, a major virion tegument protein. J. Virol. 75:8697-8711.
43. Cai M, Wang S, Xing J, Zheng C. 2011. Characterization of the nuclear import and export signals, and subcellular transport mechanism of varicella-zoster virus ORF9. J. Gen. Virol. 92:621-626.
44. Pomeranz LE, Blaho JA. 1999. Modified VP22 localizes to the cell nucleus during synchronized herpes simplex virus type 1 infection. J. Virol. 73: 6769-6781.
45. Ingvarsdottir K, Blaho JA. 2010. Association of the herpes simplex virus major tegument structural protein VP22 with chromatin. Biochim. Biophys. Acta 1799:200-206.
46. Lopez MR, Schlegel EF, Wintersteller S, Blaho JA. 2008. The major tegument structural protein VP22 targets areas of dispersed nucleolin and marginalized chromatin during productive herpes simplex virus 1 infection. Virus Res. 136:175-188.
47. Maringer K, Stylianou J, Elliott G. 2012. A Network of protein interactions around the herpes simplex virus tegument protein VP22. J. Virol. 86:12971-12982.
48. Stylianou J, Maringer K, Cook R, Bernard E, Elliott G. 2009. Virion incorporation of the herpes simplex virus type 1 tegument protein VP22 occurs via glycoprotein E-specific recruitment to the late secretory pathway. J. Virol. 83:5204-5218.
49. Elliott G, Mouzakitis G, O'Hare P. 1995. VP16 interacts via its activation domain with VP22, a tegument protein of herpes simplex virus, and is relocated to a novel macromolecular assembly in coexpressing cells. J. Virol. 69:7932-7941.
50. Elliott G, Hafezi W, Whiteley A, Bernard E. 2005. Deletion of the herpes simplex virus VP22-encoding gene (UL49) alters the expression, localization, and virion incorporation of ICP0. J. Virol. 79:9735-9745.
51. Coulter LJ, Moss HW, Lang J, McGeoch DJ. 1993. A mutant of herpes simplex virus type 1 in which the UL13 protein kinase gene is disrupted. J. Gen. Virol. 74(Part 3):387-395.
52. Kawaguchi Y, Kato K. 2003. Protein kinases conserved in herpesviruses potentially share a function mimicking the cellular protein kinase cdc2. Rev. Med. Virol. 13:331-340.
53. Krosky PM, Baek MC, Coen DM. 2003. The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J. Virol. 77:905-914.
54. Morrison EE, Wang YF, Meredith DM. 1998. Phosphorylation of structural components promotes dissociation of the herpes simplex virus type 1 tegument. J. Virol. 72:7108-7114.
55. Gershburg E, Pagano JS. 2008. Conserved herpesvirus protein kinases. Biochim. Biophys. Acta 1784:203-212.
56. Abendroth A, Arvin AM, Moffat JF. 2010. Varicella-zoster virus. Preface. Curr. Top. Microbiol. Immunol. 342:v-vi.